- COMP approved for the treatment of medullary thyroid carcinoma Zactima
AstraZeneca's ZD-6474/Zactima (vandetanib) Orphan Drugs Commission for Europe (COMP) an affirmative approval recommended for medullary thyroid carcinoma (MTC). It is administered once-daily oral treatment drug, which selectively target invo...[Read More]
- Thyroid cancer is to eat out
This may say you do not believe that thyroid cancer is to eat out, do not believe you will understand the pull-down to see! In some hospitals, clinics often see such a scene: in a large family will find a number of thyroid cancer patients;...[Read More]
Location: homepage > Thyroidcancer >
Latest News
- ·Medical Mystery: Thyroid Cancer Rates Soar
- ·Second primary malignancies in thyroid cancer patients.
- ·Seafood diet might lead to thyroid cancer
- ·Thyroid cancer raises risk of second cancer
- ·What about followup care for thyroid cancer?
- ·What are side effects of cancer treatment?
- ·What is the treatment for thyroid cancer?
- ·What are symptoms of thyroid cancer?
- ·What causes thyroid cancer, and what are risk factors of thyr
- ·What is cancer, and what are the types of thyroid cancer?
- ·Thyroid Cancer
- ·Description of thyroid cancer
- ·Classification of thyroid cancer
- ·Thyroid cancer pathology common sense
- ·Resection of thyroid cancer, why some people appear hoarsenes
Top Ten Topics
- ·Introduction to Thyroid Cancer
- ·What about followup care for th
- ·What causes thyroid cancer, and
- ·What is cancer, and what are th
- ·Thyroid nodules and differentia
- ·COMP approved for the treatment
- ·Thyroid cancer pathology common
- ·Because of thyroid cancer
- ·What is the treatment for thyro
- ·Medical Mystery: Thyroid Cancer
